RaySearch Laboratories AB (publ) and C-RAD are pleased to announce a collaboration agreement, aiming at jointly developing innovative solutions and products to enhance the quality of radiation therapy.
The focus of the collaboration is to investigate how the C-RAD surface scanning technologies can be utilized during treatment planning in RaySearch’s treatment planning system RayStation®*. Today, the surfaces from the C-RAD surface guided radiation therapy system, Catalyst+, are used during imaging and treatment. Making the Catalyst+ surfaces available in RayStation has many potential applications. One such application is to extend a cone beam CT image that has a limited field-of-view by using information from the surface scanning. This will lead to more complete representation of the patient’s anatomy, which in turn results in a more dependable basis for clinical decisions. As a first outcome of the announced collaboration, the above-described application will be demonstrated at the ongoing trade show ESTRO, with a continuation to explore other applications of the companies’ respective products.
Also Read: GeBBS Healthcare Solutions Acquires CCD Health
Cecilia de Leeuw, CEO and President, C-RAD, says: “We are thrilled about the collaboration with RaySearch, where we will enhance and find new innovative solutions in our common fight against cancer.
Johan Löf, founder and CEO, RaySearch, says: “I look forward to collaborating with C-RAD, which is also located close to us in Sweden. The additional information about the patient’s anatomy provided by surface scanning from Catalyst+ has the potential to greatly improve different steps in the radiation therapy treatment planning process in RayStation.”
RaySearch is advancing cancer treatment through pioneering software. Software has unlimited potential, and we believe it is now the driving force for innovation in oncology. Medical science never stands still, and neither does RaySearch. We work in close cooperation with leading cancer centers to bring scientific advancements faster to the clinical world. Today, our solutions support thousands of clinics worldwide in the fight against cancer.
SOURCE: PRNewswire